Focused Issue Dedicated to the 9th International Thymic Malignancy Interest Group Annual Meeting (ITMIG 2018)

Posted On 2019-06-24 11:14:46


This focused issue dedicated to the 9th International Thymic Malignancy Interest Group Annual Meeting (ITMIG 2018) is edited by Dr. Brett W. Carter, from Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; and Dr. Mirella Marino, from Department of Pathology, Regina Elena National Cancer Institute, Rome, Italy.

Dr. Brett W. Carter is an Associate Professor of Radiology at the University of Texas MD Anderson Cancer Center in Houston, Texas. He currently serves as Director of Thoracic CT, Co-Director of Thoracic MRI, Clinical Co-Director of the Quantitative Imaging Analysis Core (QIAC), Co-Director of the Imaging Response Assessment Team (IRAT), and Co-Chair of the Diagnostic Radiology Peer Review Committee (DRPRC). He is the author/co-author of over 70 publications, 90 abstracts, and 120 books chapters, and the editor of 3 books.

Dr. Mirella Marino is the referral Pathologist for Haematopathology and for Thymic Epithelial Tumors (TET) (diagnostics and research). In the Pathology Department she also serves as Quality assurance, Clinical Risk and Biobank Quality responsible. Dr. Marino is involved in diagnostic surgical pathology of every organ/system; her main diagnostic and research interests are haematopathology/thymic pathology. She has been leading the research activity in TET for the last 16 years at the RE-NCI and contributed to TET international research projects and to WHO TET classification.

Focused issue outline:
  1. Preface to this focused issue
    Brett W. Carter, Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Mirella Marino, Department of Pathology, Regina Elena National Cancer Institute, Rome, Italy
  2. Approach to the prevascular mass
    Noriyuki Tomiyama, Department of Radiology, Osaka University Graduate School of Medicine, Osaka, Japan
  3. Clinical TNM staging of thymic epithelial malignancies
    Jeanne Ackman, Division of Thoracic Imaging and Intervention, Massachusetts General Hospital, Boston, MA, USA
  4. Determining extent of invasion and follow-up of thymic epithelial malignancies
    Marcelo Benveniste, Division of Diagnostic Imaging, the University of Texas MD Anderson Cancer Center Houston, TX, USA
  5. Management of incidental anterior mediastinal lesions: summary of relevant studies
    Soon Ho Yoon, Department of Radiology, Seoul National University Hospital, Seoul National College of Medicine, Seoul, Korea
  6. Red flags in minimally invasive thymoma resections
    Alper Toker, Department of Thoracic Surgery, Istanbul University, Istanbul Medical School, Istanbul, Turkey
  7. Is there a threshold for getting over the learning curve for MIS for TET?
    Josh Sonett, Section of Thoracic Surgery, Columbia University/New-York Presbyterian Hospital, New York, NY, USA
  8. Initiating a MIS TET program: case selection, simulation, proctorship
    Franca Melfi, Unit of Minimally Invasive and Robotic Thoracic Surgery, Robotic Multispeciality Center for Surgery, University Hospital of Pisa, Pisa, Italy
  9. Using CUSUM monitoring of a new program
    Nuria Novoa, Department of Surgery, Service of Thoracic Surgery, Salamanca University Hospital, Salamanca, Spain
  10. Endoscopic lymph node dissection for thymic malignancies: lateral thoracic intercostal and subxiphoid approaches
    Takashi Suda, Department of Thoracic Surgery, Fujita Health University School of Medicine, Aichi, Japan
  11. Extent of node assessment and 9th edition refinement of TNM stage classification
    Enrico Ruffini, Department of Thoracic Surgery, University of Torino, Torino, Italy
  12. Chemotherapy for stage IVA thymic tumors: neoadjuvant or adjuvant, intrapleural or systemic?
    Nicolas Girard, Université de Lyon, Université Claude Bernard Lyon1, Lyon, France
  13. Radiotherapy for stage IVa thymoma—Shanghai Chest experience
    Changlu Wang, Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China
  14. Deciphering the biology of thymic tumors
    Arun Rajan, Thoracic and Gastrointestinal Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
  15. Next generation sequencing: is it useful for routine practice?
    Nicolas Girard, Université de Lyon, Université Claude Bernard Lyon1, Lyon, France
  16. Immune checkpoint inhibitors: how to move forward?
    Arun Rajan, Thoracic and Gastrointestinal Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA